Vijay Shankarlal Bankda

Biography

 Syncom Formulations (India) Ltd (Syncom) was established in the year 1995. The company is an integrated pharmaceutical company catering to both domestic and global markets. Syncom is engaged in manufacturing and marketing of generics and pharmaceutical formulations. The company manufactures and markets over 500 pharmaceutical formulations in various dosage forms like tablets, capsules, liquid orals, liquid vials, ampoule injections, dry vial injections, dry syrup, ointments, inhalers and herbals. Syncom covers a wide range of therapeutic areas including inflammatory, anti-fungal, anti-malarial, cough suppressant, anti-ulcer, cardiology, erectile dysfunction, homeostatic, central nervous stimulant, analgesic and antipyretic amongst others. Some of the brands under which it market its products include Venegra, Rofin, Transquine, Ladinax, Ciprojet, Ceftazidime, Cefnat, Rovamid, Kamurja, Hypercon, Debetus, Raatrani and Crataksun amongst others. The company operates through its manufacturing facility located at Pithampur in Indore.

Research Interest

 Syncom Formulations (india) Limited is a Public incorporated on 21 June 1988. It is classified as Non-govt company and is registered at Registrar of Companies, Mumbai. Its authorized share capital is Rs. 800,000,000 and its paid up capital is Rs. 780,652,160.It is inolved in Manufacture of other chemical products